EVLV:NASDAQEvolv Technologies Holdings, Inc. Analysis
Data as of 2026-08-30 - not real-time
$5.24
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Evolv Technologies Holdings, Inc. is priced at $5.24 and its moving averages line up in bearish order, the shorter trailing the longer. Across the trailing 30 sessions it lost 7.4%. With RSI at 40.3 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $5.17 and resistance at $6.17.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 96.8% above the current price. Revenue is growing at 34.4% on a -3.0% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 45.5%, a beta of 1.31 and a maximum drawdown of 44.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: sell, at a conviction of 4 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 96.8% above the current price. Revenue is growing at 34.4% on a -3.0% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 45.5%, a beta of 1.31 and a maximum drawdown of 44.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: sell, at a conviction of 4 out of 10.
Top Market Events
Evolv Technologies Holdings Inc EVLV reports a 45% increase in revenue and raises full-year guidance, despite facing...Evolv Technologies Holdings Inc EVLV reports a 34% revenue surge and its strongest quarter for new customer additions...Evolv Technologies Holdings EVLV has caught Wall Street’s attention after releasing its Q2 results, showing 29%...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 6.08
- MACD momentum is negative
Medium Term
1–3 yearsCautious
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 6.08
- Analyst targets imply +96.8% versus the current price
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Negative profit margin of -3.0%
- Analyst targets imply +96.8% versus the current price
- Negative return on equity of -4.9%
Key Metrics & Analysis
Financial Health
Revenue Growth34.40%
Profit Margin-3.05%
P/E Ratio-142.9
ROE-4.94%
ROA-5.33%
Debt/Equity34.97
P/B Ratio8.0
Op. Cash Flow$27.8M
Free Cash Flow$-7591500
Industry P/E29.4
Technical Analysis
TrendBearish
RSI40.3
Support$5.17
Resistance$6.17
MA 20$5.62
MA 50$5.68
MA 200$6.08
MACDBearish
VolumeDecreasing
Fear & Greed Index95.66
Valuation
Fair Value$3.91
Target Price$10.31
Upside/Downside96.80%
GradeFair
TypeGrowth
Risk Assessment
Beta1.31
Volatility45.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.